Other risk factors that may increase vulnerability include: Long duration of diabetes (typically more than 10 years) Poor glycaemic control prior to starting GLP-1 therapy (HbA1c significantly above target) Rapid reduction in HbA1c (a drop of more than 2 percentage points [22 mmol/mol] within 36 months) Concurrent hypertension , especially if poorly controlled Diabetic kidney disease (nephropathy), which often correlates with retinopathy severity Previous history of retinal treatment (laser photocoagulation or intravitreal injections) People with type 2 diabetes but no retinopathy appear to have minimal risk of retinopathy progression based on current evidence
This has occurred partly due to the very success of these drugs, and the lack of availability may result in patients being unable to persist with the drug
Inspect before use if it's cloudy or has visible particles, discard it
Other ingredients: Brown rice flour, hypromellose (vegetable capsule), may contain one or both of the following: magnesium stearate, silica
NMN is an abbreviation for "-nicotinamide mononucleotide"
Iontophoresis This is an in-patient medical procedure that uses a small electrical current to temporarily reduce sweating, specifically for hands and feet
